Literature DB >> 376140

Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.

S I Lamberg, S B Green, D P Byar, J B Block, W E Clendenning, E H Epstein, Z Y Fuks, L E Golitz, A L Lorincz, B Michel, H H Roenigk, E J Van Scott, E C Vonderheid, R J Thomas.   

Abstract

The frequency and prognostic importance of various characteristics of patients registered by the Mycosis Fungoides Cooperative Group between November 1974 and December 1977 are reported. Variables which were considered include demographic and historical factors, symptoms, extent of disease, and other physical findings. A staging system which is based on the extent of skin involvement and the number of nodal sites clinically involved is described. Finally, a description of therapeutic results to date for patients randomized into Mycosis Fungoides Cooperative Group protocols is presented.

Entities:  

Mesh:

Year:  1979        PMID: 376140

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  Extracorporeal photophoresis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-03-01

2.  Cutaneous T cell lymphoma (mycosis fungoides) in blacks.

Authors:  I S Hong; G Johnson; J Kovi
Journal:  J Natl Med Assoc       Date:  1981-09       Impact factor: 1.798

3.  The immunological profile of mycosis fungoides.

Authors:  J R Jensen; K Thestrup-Pedersen; S Ahrons; H Zachariae
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

4.  Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.

Authors:  B Prinz; W Behrens; E Hölzle; G Plewig
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Mycosis fungoides: developments in incidence, treatment and survival.

Authors:  A E Kaufman; K Patel; K Goyal; D O'Leary; N Rubin; D Pearson; K Bohjanen; A Goyal
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-24       Impact factor: 6.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.